Hematology & Oncology Doctors in Orange Park, FL Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Jeffrey M Harris, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2141 Loch Rane Blvd Ste 116, Orange Park, FL 32073 Phone: 904-427-1270

Dr. Yan G Makeyev, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2141 Loch Rane Blvd Ste 116, Orange Park, FL 32073 Phone: 904-427-1270

Dr. Linda Sylvester, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2161 Kingsley Ave., Suite 200, Orange Park, FL 32073 Phone: 904-276-2303    Fax: 904-272-6521

Dr. Kelley A Trent, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2161 Kingsley Ave, Ste 200, Orange Park, FL 32073 Phone: 904-272-3139    Fax: 904-276-7374

Dr. Kenneth H Goldstein, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2161 Kingsley Ave., Suite 200, Orange Park, FL 32073 Phone: 904-276-2303    Fax: 904-272-3659

News Archive

Research suggests that Ginkgo biloba extract contains naturally occurring inhibitors against SARS-CoV-2

Researchers at Shihezi University in China found that Gingko Biloba leaves extract contains the most potent SARS-CoV-2 3-Chymotrypsin-like protease (3CLpro). This virally encoded main proteinase is essential for viral replication in coronaviruses.

Quest Diagnostics on Dow Jones Sustainability World and North America indexes

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its seventh year on the World Index (since 2004) and in its sixth on the North American Index (since 2005).

Wireless Health 2014 international conference to highlight latest developments in mobile health

From the benefits of wearable devices for remote patient monitoring to opportunities for big-data applications to a changing regulatory environment, the Wireless Health 2014 international conference here Oct. 29 – 31 aims to disseminate the latest advances and promising prospective developments in mobile health.

Integral Molecular wins NIH grant to initiate target discovery program for Alzheimer's disease

Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.

Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.

Read more Medical News

› Verified 5 days ago